Norepinephrine transmitter metabolite generates free radicals and activates mitochondrial permeability transition: A mechanism for DOPEGAL- induced apoptosis

Brain Research

Volumn 787, Issue 2, 1998, Pages 328-332

  Burke, William J ^a   Kristal, Bruce S ^b,c   Yu, Byung P ^d   Li, Shu Wen ^a   Lin, Tien Sung ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BURKE MEDICAL RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e WASHINGTON UNIVERSITY   (United States)

Author keywords

3,4 Dihydroxyphenylglycolaldehyde; Alzheimer's disease; Apoptosis; Mitochondrial permeability transition; Neurotoxin

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; CALCIUM ION; FREE RADICAL;

ANIMAL CELL; APOPTOSIS; ARTICLE; LIVER MITOCHONDRION; MALE; NONHUMAN; OXIDATIVE STRESS; PERMEABILITY; PRIORITY JOURNAL; RAT;

ALDEHYDES; ANIMALS; APOPTOSIS; CALCIUM; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICALS; MALE; MITOCHONDRIA, LIVER; NOREPINEPHRINE; OXIDATIVE STRESS; PC12 CELLS; PERMEABILITY; RATS; RATS, INBRED F344;

EID: 0032559880     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01488-1     Document Type: Article

References (39)

1. Arango V., Ruggiero D.A., Callaway J.L., Anwar M., Mann J.J., Reis D.J. Catecholaminergic neurons in the ventrolateral medulla and nucleus of the solitary tract in the human. J. Comp. Neurol. 273:1988;224-240.
2. Blaschko H. Amine oxidase and amine metabolism. Pharmacol. Rev. 4:1952;415-453.
3. Bondareff W., Mountjoy C.D., Roth M. Loss of neurons of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology. 31:1982;164-168.
4. Burke W.J., Mattammal M.B., Marshall G.L., Chung H.D. Detection of 3,4-dihydroxyphenylglycolaldehyde in human brain by high-performance liquid chromatography. Anal. Biochem. 180:1989;79-84.
5. Burke W.J., Chung H.D., Marshall G.L., Gillespie K.N., Joh T.H. Evidence for decreased transport of PNMT protein in advanced Alzheimer's disease. J. Am. Geriatr. Soc. 38:1990;1275-1282.
6. Burke W.J., Park D.H., Chung H.D., Marshall G.L., Haring J.H., Joh T.H. Evidence for decreased transport of tryptophan hydroxylase in Alzheimer's disease. Brain Res. 537:1990;83-87.
7. Burke W.J., Galvin N.J., Chung H.D., Stoff S.A., Gillespie K.N., Cataldo A.M., Nixon R.A. Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease. Brain Res. 661:1994;35-42.
8. Burke W.J., Schmitt C.A., Li S.W., Gillespie K.N., Park D.H., Joh T.H. Measurement of enzyme activity, protein, mRNA and metabolites in small samples. Anal. Biochem. 230:1995;345-348.
9. Burke W.J., Schmitt C.A., Gillespie K.N., Li S.W. Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells. Brain Res. 722:1996;232-235.
10. Burke W.J., Schmitt C.A., Miller C., Li S.W., Barg J., Kristal B.S., Yu B.P. Mechanism of toxicity of 3,4-dihydroxyphenylglycolaldehyde in differentiated PC-12 cells: a model for adrenergic neuronal death in Alzheimer's disease. Neurology. 46:1996;A265.
11. W.J. Burke, C.A. Schmitt, C. Miller, S.W. Li, Norepinephrine transmitter metabolite induces apoptosis in differentiated rat pheochromocytoma cells, Brain Res., 1997, in press.
12. Cohen G., Heikkila R.E. The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J. Biol. Chem. 249:1974;2447-2452.
13. Dugan L.L., Sensi S.L., Canzoniero L.M.T., Handran S.D., Rothman S.M., Lin T.-S., Goldberg M.P., Choi D.W. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15:1995;6377-6388.
14. A.B. Fisher, Intracellular production of oxygen-derived free radicals, in: B. Halliwell (Ed.), Oxygen Radicals and Tissue Injury, Federation of American Societies for Experimental Biology, Bethesda, 1988, pp. 34-39.
15. Gai W.P., Geffen L.B., Denoroy L., Blessing W.W. Loss of C-1 and C-3 epinephrine-synthesizing neurons in medulla oblongata in Parkinson's disease. Ann. Neurol. 33:1993;357-367.
16. M. Goldstein, J. Pearson, A. Sauter, K. Veta, T.Y. Asano, J. Engel, P. Passeltiner, T. Hokfelt, K. Fuxe, Distribution and characterization of PNMT and epinephrine in the CNS, In: K. Fuxe, M. Goldstein, B. Hokfelt, T. Hokfelt (Eds.), Central Adrenaline Neurons: Basic Aspects and Their Role in Cardiovascular Functions, Elsevier, Oxford, 1980, pp. 49-55.
17. Green L.A. Establishment of noradrenergic clonal lines of rat pheochromocytoma cells which respond to nerve cell growth factor. Proc. Natl. Acad. Sci. U.S.A. 73:1976;2424-2429.
18. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
19. Kristal B.S., Park B.K., Yu B.P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271:1996;6033-6038.
20. Kristal B.S., Dubinsky J.M. Mitochondrial permeability transition in the central nervous system: induction by calcium cycling dependent and independent pathways. J. Neurochem. 69:1997;524-538.
21. Lassman H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:1995;35-41.
22. Layne E. Spectrophotometric and turbidimetric methods for measuring proteins. Meth. Enzymol. 3:1957;447-451.
23. Li S.W., Elliott W.H., Burke W.J. Synthesis of a biochemically important aldehyde, 3,4-dihydroxyphenylglycolaldehyde. Bioorg. Chem. 22:1994;337-342.
24. Li S.W., Spaziano V.T., Elliott W.H., Burke W.J. Synthesis and use of deuterated 3,4-dihydroxyphenylglycolaldehyde as an internal standard for determination of DOPEGAL in brain tissue by gas chromatography-mass spectrometry. Bioorg. Chem. 24:1996;169-177.
25. Liu J., Mori A. Monamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage. Arch. Biochem. Biophys. 302:1993;127-188.
26. Markey J.P., Johanessen J.N., Chiveh C.C., Burne S.S., Herkenham M.A. Intraneuronal generation of pyridinium metabolite may cause drug-induced Parkinsonism. Nature. 311:1984;464-467.
27. Nieminen A.L., Petrie T.G., Lemasters J.J., Selman W.R. Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons: evidence of the mitochondrial permeability transition. Neuroscience. 75:1996;993-997.
28. Orrenius S., Nicotera P. The calcium ion and cell death. J. Neural Transm. 43:1994;1-11.
29. 2+ release from mitochondria induced by prooxidants. Free Radic. Biol. Med. 4:1988;365-375.
30. Rigobello M.P., Toninello A., Siliprandi D., Bindoli A. Effect of spermine on mitochondrial glutathione release. Biochem. Biophys. Res. Commun. 194:1993;1276-1281.
31. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med. 336:1997;1216-1222.
32. Schinder A.F., Olson E.C., Spitzer N.C., Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16:1996;6125-6133.
33. Strittmatter W.J., Weisgraber K.H., Goedert M., Saunders A.M., Huang D., Corder E.H., Dong L.-M., Jakes R., Alberts M.J., Gilbert J.R., Han S.-H., Hulette C., Einstein G., Schmechl D.E., Pericak-Vance M.A., Roses A.D. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125:1994;163-171.
34. Susin S.-A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331-1341.
35. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1994;1456-1462.
36. Westlund K.N., Denney R.M., Kochersperger L.M., Rose R.M., Abell C.W. Distinct monamine oxidase A and B populations in primate brain. Science. 230:1985;181-183.
37. Younkin S.G., Goodridge B., Katz J., Lockett G., Nafziger D., Usiak M.F., Younkin L.H. Molecular forms of acetylcholine esterase in Alzheimer's disease. Fed. Proc. 45:1988;2982-2988.
38. White R.J., Reynolds I.J. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal to excitotoxic exposure. J. Neurosci. 16:1996;5688-5697.
39. Zoratti M., Szabo I. The mitochondrial permeability transition. Biochim. Biophys. Acta. 1241:1995;139-176.